[{"NetIncomeLoss_1_Q2_USD":72843000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.007,"OtherAssetsNoncurrent_0_Q2_USD":115000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":202771000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":8371000.0,"Liabilities_0_Q2_USD":460669000.0,"ConvertibleLongTermNotesPayable_0_Q2_USD":139511000.0,"AccruedRoyaltiesCurrent_0_Q2_USD":14312000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":67181000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":27386000.0,"InterestPaidNet_2_Q2_USD":9348000.0,"InventoryFinishedGoods_0_Q2_USD":9500000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":2547000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"AmortizationOfIntangibleAssets_1_Q2_USD":16795000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-1153000.0,"CostOfGoodsAndServicesSoldAmortization_2_Q2_USD":33590000.0,"CostOfGoodsAndServicesSoldAmortization_1_Q2_USD":16795000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_2_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":318532000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":61844000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":30368000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":64826000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":32703000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":4093000.0,"IncomeTaxesPaidNet_2_Q2_USD":876000.0,"CommonStockSharesIssued_0_Q2_shares":35523917.0,"Assets_0_Q2_USD":713735000.0,"ShareBasedCompensation_2_Q2_USD":13395000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":8023000.0,"Depreciation_2_Q2_USD":864000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":33590000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-2472000.0,"IncreaseDecreaseInInventories_2_Q2_USD":4498000.0,"CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_2_Q2_USD":31236000.0,"CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_1_Q2_USD":15908000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":6392000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":3462000.0,"InventoryRawMaterials_0_Q2_USD":6100000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":218856000.0,"EarningsPerShareBasic_2_Q2_USD":2.52,"EarningsPerShareBasic_1_Q2_USD":2.06,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":67181000.0,"AccruedBonusesCurrent_0_Q2_USD":1860000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":41251749.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":41286853.0,"LoansPayableCurrent_0_Q2_USD":47919000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":2969000.0,"AccountsReceivableNetCurrent_0_Q2_USD":90098000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.672,"IncomeTaxExpenseBenefit_2_Q2_USD":-62040000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_2_Q2_USD":0.0,"WarrantsNotSettleableInCashFairValueDisclosure_0_Q2_USD":8043000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_2_Q2_USD":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-20297000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":-5.628,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":-2.344,"InvestmentIncomeNet_1_Q2_USD":3000.0,"InvestmentIncomeNet_2_Q2_USD":6000.0,"NetIncomeLossAttributableToParentDiluted_1_Q2_USD":74011000.0,"NetIncomeLossAttributableToParentDiluted_2_Q2_USD":90838000.0,"CommonStockValue_0_Q2_USD":36000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-61852000.0,"InterestPayableCurrent_0_Q2_USD":1415000.0,"RepaymentsOfNotesPayable_2_Q2_USD":25000000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":62649000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":67180000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":67181000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":26465000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":10991000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":3929000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":6516000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":50105000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":35128144.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":35302608.0,"InventoryWorkInProcess_0_Q2_USD":3995000.0,"LiabilitiesCurrent_0_Q2_USD":226843000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":28655000.0,"AccountsPayableCurrent_0_Q2_USD":7543000.0,"InterestExpense_2_Q2_USD":11142000.0,"InterestExpense_1_Q2_USD":5421000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":205318000.0,"NetIncomeLoss_2_Q2_USD":88505000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":19555000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_2_Q2_USD":0.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":302314000.0,"AdditionalPaidInCapital_0_Q2_USD":492384000.0,"GrossProfit_1_Q2_USD":50239000.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_2_Q2_USD":55000.0,"GrossProfit_2_Q2_USD":105837000.0,"InterestExpenseDebt_1_Q2_USD":1168000.0,"InterestExpenseDebt_2_Q2_USD":2333000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":1545000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":8274000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":6068000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":358000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":104000.0,"LongTermLoansPayable_0_Q2_USD":85944000.0,"EarningsPerShareDiluted_1_Q2_USD":1.79,"CommonStockSharesOutstanding_0_Q2_shares":35523917.0,"ConvertibleDebtFairValueDisclosures_0_Q2_USD":162337000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1301000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":170663000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":82942000.0,"OperatingIncomeLoss_2_Q2_USD":37601000.0,"OperatingIncomeLoss_1_Q2_USD":16409000.0,"InventoryNet_0_Q2_USD":19595000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":521170000.0,"PreferredStockValue_0_Q2_USD":null,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-62649000.0,"DeferredIncomeTaxExpenseBenefit_1_Q2_USD":-62649000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":713735000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":1827000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":13395000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":6778000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-239354000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":1795000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q2_USD":302314000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1153000.0,"AccruedMarketingCostsCurrent_0_Q2_USD":839000.0,"EarningsPerShareDiluted_2_Q2_USD":2.2,"StockholdersEquity_0_Q2_USD":253066000.0,"OperatingExpenses_2_Q2_USD":68236000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":33591000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":771000.0,"DeferredTaxAssetsValuationAllowance_0_Q2_USD":1966000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":56389000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":6516000.0,"OperatingExpenses_1_Q2_USD":33830000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":1775000.0,"Ticker":"COLL","CIK":"1267565","name":"COLLEGIUM PHARMACEUTICAL, INC","OfficialName":"Collegium Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"619097451.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]